Science news

US FDA accepts Cytovation's IND application for Phase II combination studies of CyPep-1, a first-in-class targeted tumor membrane immunotherapy

BERGEN, Norway, May 19, 2022 /PRNewswire/ -- Cytovation ASA, a clinical stage immune-oncology company focused on the development of CyPep-1, its first-in-class targeted tumor...

USD 622.43 million Potential Growth in Adhesive Bandages Market Size | 17,000+ Technavio Reports

NEW YORK, May 18, 2022 /PRNewswire/ -- The latest market outlook report titled "Adhesive Bandages Market by Product and Geography - Forecast and Analysis...

Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBD

Novel proprietary cannabidiol (CBD) therapeutic has been classified as an orphan medicinal product for the indication of epidermolysis bullosa (EB).Drug is ready for human...

Blue Light Cystoscopy continues to make news at AUA 2022

OSLO, Norway, May 18, 2022 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the conclusion of a productive AUA 2022 Conference: the...

Energia Holdings Incorporated Hosts THE FIRST-EVER MEDICAL PSYCHEDELICS SERIES AT DAVOS 2022

Join us for an exclusive, week-long journey at the Medical Psychedelics House of Davos to experience educational talks by subject matter experts and have the...

Neighbourly Announces Timing of Fourth Quarter and Fiscal 2022 Earnings Release

TORONTO, May 17, 2022 /CNW/ - Neighbourly Pharmacy Inc. ("Neighbourly" or the "Company") (TSX: NBLY), Canada's largest and fastest growing network of community pharmacies,...

Vascular Endothelial Growth Factor (VGEF) Inhibitors Market: 36% Market Growth to Originate from North America | Technavio

NEW YORK, May 17, 2022 /PRNewswire/ -- Technavio categorizes the global vascular endothelial growth factor (VEGF) inhibitors market as a part of the pharmaceutical market...

Latest articles